Sativex Oromucosal


What it is used for

Sativex is indicated as treatment, for symptom improvement in patients with moderate to severe spasticity due to multiple sclerosis (MS) who have not responded adequately to other anti-spasticity medication and who demonstrate clinically significant improvement in spasticity related symptoms during an initial trial of therapy.


How to take it

The way to take this medicine is: Oromucosal.

  • Store at 2 to 8 degrees Celsius
  • Refrigerate
  • Replace the cover firmly after use
  • Store Upright
  • Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.


Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems


How to take it

The way to take this medicine is: Oromucosal.

  • Store at 2 to 8 degrees Celsius
  • Refrigerate
  • Replace the cover firmly after use
  • Store Upright
  • Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.


Pregnant or planning a pregnancy?

For the active ingredient nabiximols

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.


Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.


Visual appearance

Yellow/brown solution in a brown, plastic-coated glass spray container

0 0 votes
Do you use this medicine? Rate it:
Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments